Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronen Loebstein

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
The Israel Medical Association Journal : IMAJ|November 26, 2013
"Body packers" in Israel: a case seriesNoa Markovits, Daniel Kurnik, Hillel Halkin, et al.
The Israel Medical Association Journal : IMAJ|December 17, 2008
Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factorsRonen Loebstein, Rafae Mahagna, Yasmin Maor, et al.
British Journal of Clinical Pharmacology|March 6, 2021
Pregnancy outcomes following gestational exposure to papaverine: An observational comparative studyItai Gueta, Adi Braun, Adi Gilan, et al.
Journal of Applied Genetics|January 16, 2014
The VKORC1 Asp36Tyr variant and VKORC1 haplotype diversity in Ashkenazi and Ethiopian populationsSophia Sominsky, Michael Korostishevsky, Daniel Kurnik, et al.
Leukemia & Lymphoma|April 27, 2022
Effects of imatinib on glycemic and lipid profiles: a retrospective cohort studyNoa Markovits, Daniel Kurnik, Carmel Friedrich, et al.
Journal of Clinical Pharmacology|May 21, 2010
Database evaluation of the effects of long-term rosiglitazone treatment on cardiovascular outcomes in patients with type 2 diabetesRonen Loebstein, Marina Dushinat, Janet Vesterman-Landes, et al.
Thrombosis and Haemostasis|August 9, 2012
Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose predictionDaniel Kurnik, Husam Qasim, Sophie Sominsky, et al.
Blood|November 18, 2006
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistanceRonen Loebstein, Ilana Dvoskin, Hillel Halkin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2015
Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel DiseasesBella Ungar, Idan Levy, Yarden Yavne, et al.
Journal of Clinical Pharmacology|February 28, 2002
Serum concentrations, efficacy, and safety of a new, intravenously administered varicella zoster immune globulin in pregnant womenGideon Koren, Deborah Money, Marc Boucher, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
The Israel Medical Association Journal : IMAJ|November 26, 2013
"Body packers" in Israel: a case seriesNoa Markovits, Daniel Kurnik, Hillel Halkin, et al.
The Israel Medical Association Journal : IMAJ|December 17, 2008
Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factorsRonen Loebstein, Rafae Mahagna, Yasmin Maor, et al.
British Journal of Clinical Pharmacology|March 6, 2021
Pregnancy outcomes following gestational exposure to papaverine: An observational comparative studyItai Gueta, Adi Braun, Adi Gilan, et al.
Journal of Applied Genetics|January 16, 2014
The VKORC1 Asp36Tyr variant and VKORC1 haplotype diversity in Ashkenazi and Ethiopian populationsSophia Sominsky, Michael Korostishevsky, Daniel Kurnik, et al.
Leukemia & Lymphoma|April 27, 2022
Effects of imatinib on glycemic and lipid profiles: a retrospective cohort studyNoa Markovits, Daniel Kurnik, Carmel Friedrich, et al.
Journal of Clinical Pharmacology|May 21, 2010
Database evaluation of the effects of long-term rosiglitazone treatment on cardiovascular outcomes in patients with type 2 diabetesRonen Loebstein, Marina Dushinat, Janet Vesterman-Landes, et al.
Thrombosis and Haemostasis|August 9, 2012
Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose predictionDaniel Kurnik, Husam Qasim, Sophie Sominsky, et al.
Blood|November 18, 2006
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistanceRonen Loebstein, Ilana Dvoskin, Hillel Halkin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2015
Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel DiseasesBella Ungar, Idan Levy, Yarden Yavne, et al.
Journal of Clinical Pharmacology|February 28, 2002
Serum concentrations, efficacy, and safety of a new, intravenously administered varicella zoster immune globulin in pregnant womenGideon Koren, Deborah Money, Marc Boucher, et al.
Pageof 7